A Technical Review: Solid- Lipid Nanoparticle (SLN), Their Characteristics and Their Preparation

  • Sunirmal Bhattacharjee Department of Pharmaceutics, Bharat Pharmaceutical Technology, Amtali, NH-8, Agartala, Tripura, India.
  • Rabindra Debnath Department of Pharmaceutics, Bharat Pharmaceutical Technology, Amtali, NH-8, Agartala, Tripura, India.
  • Sinha Ashutosh Kumar Department of Pharmaceutics, Bharat Pharmaceutical Technology, Amtali, NH-8, Agartala, Tripura, India.
  • Arpan Saha Department of Pharmaceutics, Bharat Pharmaceutical Technology, Amtali, NH-8, Agartala, Tripura, India.
  • Surajit Saha Department of Pharmaceutics, Bharat Pharmaceutical Technology, Amtali, NH-8, Agartala, Tripura, India.
  • Sujata Debnath Department of Pharmaceutics, Bharat Pharmaceutical Technology, Amtali, NH-8, Agartala, Tripura, India.

Abstract

Solid lipid nanoparticles are at the forefront of the rapidly developing field of nanotechnology with several potential applications in drug delivery, clinical medicine and research as well as in other varied sciences. Due to their unique size-dependent properties, lipid nanoparticles offer the possibility to develop new therapeutics. The ability to incorporate drugs into nanocarriers offers a new prototype in drug delivery that could be used for secondary and tertiary levels of drug targeting. Hence, solid lipid nanoparticles hold great promise for reaching the goal of controlled and site specific drug delivery and hence have attracted wide attention of researchers. This review presents a broad treatment of solid lipid nanoparticles discussing their advantages, limitations and their possible remedies. The different types of nanocarriers which were based on solid lipid like solid lipid nanoparticles, nanostructured lipid carriers, lipid drug conjugates are discussed with their structural differences. Different production methods which are suitable for large scale production and applications of solid lipid nanoparticles are described. Appropriate analytical techniques for characterization of solid lipid nanoparticles like photon correlation spectroscopy, scanning electron microscopy, differential scanning calorimetry are highlighted. Aspects of solid lipid nanoparticles route of administration and their biodistribution are also incorporated. If appropriately investigated,solid lipid nanoparticles may open new vistas in therapy of complex diseases.


 

Keywords: Solid lipid nanoparticles, colloidal carriers, DLS, DSC, Homogenization, TEM, PCS.

Downloads

Download data is not yet available.

Author Biographies

Sunirmal Bhattacharjee, Department of Pharmaceutics, Bharat Pharmaceutical Technology, Amtali, NH-8, Agartala, Tripura, India.

Department of Pharmaceutics, Bharat Pharmaceutical Technology, Amtali, NH-8, Agartala, Tripura, India.

Rabindra Debnath, Department of Pharmaceutics, Bharat Pharmaceutical Technology, Amtali, NH-8, Agartala, Tripura, India.

Department of Pharmaceutics, Bharat Pharmaceutical Technology, Amtali, NH-8, Agartala, Tripura, India.

Sinha Ashutosh Kumar, Department of Pharmaceutics, Bharat Pharmaceutical Technology, Amtali, NH-8, Agartala, Tripura, India.

Department of Pharmaceutics, Bharat Pharmaceutical Technology, Amtali, NH-8, Agartala, Tripura, India.

Arpan Saha, Department of Pharmaceutics, Bharat Pharmaceutical Technology, Amtali, NH-8, Agartala, Tripura, India.

Department of Pharmaceutics, Bharat Pharmaceutical Technology, Amtali, NH-8, Agartala, Tripura, India.

Surajit Saha, Department of Pharmaceutics, Bharat Pharmaceutical Technology, Amtali, NH-8, Agartala, Tripura, India.

Department of Pharmaceutics, Bharat Pharmaceutical Technology, Amtali, NH-8, Agartala, Tripura, India.

Sujata Debnath, Department of Pharmaceutics, Bharat Pharmaceutical Technology, Amtali, NH-8, Agartala, Tripura, India.

Department of Pharmaceutics, Bharat Pharmaceutical Technology, Amtali, NH-8, Agartala, Tripura, India.

References

1. Lee WW. Chewing gum as a delivery vehicle for pharmaceutical and neutraceuticals substances. Pharm Tech Online 2001; 2:1-11.
2. Edgar W, Geddes D. Chewing gum and dental health - A review. Br Dent J 1990; 168:173-177.
3. Conway B. Chewing gum as a drug delivery system. The Drug Delivery Companies Report Autumn/Winter; 2003:33-35.
4. Patel PV, Desai TR, Dedakiya AS, Bandhiya HM. Medicated chewing gum: A review. IJUPLS 2011; 1(1):111-128.
5. Biswal PK and Kumar A. An Updated Review on Medicated Chewing Gum. IJAPBC 2013; 2(2):351-59.
6. Jacobsen J, Christrup LL, Jensen NH. Medicated chewing gum. Am J Drug Deliv 2004; 2:75-88.
7. Cloys L, Christen A, Christen J. The development & history of chewing gum. Bulletin of the History of Dentistry 1992; 40:57-65.
8. Owens, L. Gumtech to Produce Aspergum and Chooz for Schering- Plough Health Care Products. Business Wire 1998.
9. Khanekar P, Mhatre S, Momin M. Medicated Chewing Gum: A Potential Drug Delivery System. IJPFR 2012; 2(4):64-75.
10. Morjaria Y, Irwin WJ, Barnett PX, Chanvv RS, Conway BR. In vitro Release of nicotine from chewing gum formulations. Dissolution Technologies 2004; 12-15.
11. Naik H, Gupta S. Medicated Chewing Gums- Updated Review. IJPRD 2011; 2 (8):66-76.
12. Jacobsen J, Christrup LL, Jensen NH. Medicated chewing gum: Pros and Cons. Am J Drug Deliv 2004; 2(2):75-88.
13. oldberg LD, Ditchek NT. Chewing gum diarrhea, Am J Dig Dis 1978; 23(6):568-62.
14. Addy M, Roberts WR. Comparison of the bis iguanid antiseptics alexandrine and chlorhexidine II. Clinical and in vitro staining properties. J Clin. Periodontol 1981; 8(3):220-30.
15. Munksgaard EC, Nolte J, Kristensen K. Adherence of chewing gum to dental restorative materials. Am J Dent 1995; 8(3):137-139.
16. Weil AT. Coca leaf as a therapeutic agent. Am J Drug Alcohol Abuse 1978; 5(1):75-86.
17. Martin R. Chewing gum. BMJ 1985; 290:1232-1236.
18. Edgar WM, Dawes C, O’Mullane D. Saliva and oral health: An essential overview for the health professional. 3rd ed., British Dental Association Publication, London; 2004.
19. Sharma NS, Arjariya PA, Jat RC, Fiza F, Sharma G, Rathore SA, Tiwari R. An overview on medicated chewing gum and its applications. IJPFR 2013; 4(3):3158-73.
20. Zyck DJ, Greenberg MJ, Barkla DG, Marske SW, Schnell PG, Mazzone P.. Method of making coated chewing gum products containing various antacids. US Patent 2003; 6:635-45.
21. Kahtani D. Chewing gum: trick or treat.SDJ 1999; 11(1):27-34.
22. Athanikar NK, Gubler SA. Process for manufacturing a pharmaceutical chewing gum. US Patent 2001; 6:322-828.
23. Subraman CR, Kirshnayya B. Tableted chewing gum composition and method of preparation. US Patent 1988; 4:753- 805
24. Keizo M, Yokomichi FY. Process for the preparation of chewing gum. US Patent 1976; 4:321.
Statistics
42 Views | 33 Downloads
How to Cite
Bhattacharjee, S., Debnath, R., Kumar, S., Saha, A., Saha, S., & Debnath, S. (2020). A Technical Review: Solid- Lipid Nanoparticle (SLN), Their Characteristics and Their Preparation. Asian Journal of Pharmaceutical Research and Development, 8(3), 185-189. https://doi.org/https://doi.org/10.22270/ajprd.v8i3.764